| Sikandar Murad, MD | |
|
802 N University Ave, Little Rock, AR 72205-2920 | |
| (501) 291-2322 | |
| (888) 388-5166 |
| Full Name | Sikandar Murad |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 802 N University Ave, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003875501 | NPI | - | NPPES |
| 200082420A | Medicaid | OK | |
| 158950001 | Medicaid | AR | |
| 5N275 | Other | AR | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | E-4470 (Arkansas) | Secondary |
| 207Q00000X | Family Medicine | E-4470 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Regional Health System | Conway, AR | Hospital |
| Entity Name | Lahore Medical, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740512474 PECOS PAC ID: 5193841120 Enrollment ID: O20100928000810 |
News Archive
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
There are many health effects that a patient may need to overcome after winning a battle against cancer. Cancer treatments can affect the patient's balance, agility, coordination, prompt weight gain and other physical ailments. At Nationwide Children's Hospital, beating cancer doesn't mark the end of a child's treatment regimen. A new exercise program at the hospital helps pediatric cancer survivors and those in remission regain both physical strength and confidence.
Adverse events associated with taking opioid pain medications increase in patients who concurrently use sedatives and alcohol. A study in The Journal of Pain, published by the American Pain Society, advises physicians to use caution in prescribing sedatives for patients taking opioids, even if there is no history of substance abuse.
More should be done across Europe to ensure that people with rare forms of cancer are not denied access to the best possible treatment, say the organizers of a major European cancer conference to be held in Milan on 9 and 10 March 2010.
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sikandar Murad, MD 802 N University Ave, Little Rock, AR 72205-2920 Ph: (501) 291-2322 | Sikandar Murad, MD 802 N University Ave, Little Rock, AR 72205-2920 Ph: (501) 291-2322 |
News Archive
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
There are many health effects that a patient may need to overcome after winning a battle against cancer. Cancer treatments can affect the patient's balance, agility, coordination, prompt weight gain and other physical ailments. At Nationwide Children's Hospital, beating cancer doesn't mark the end of a child's treatment regimen. A new exercise program at the hospital helps pediatric cancer survivors and those in remission regain both physical strength and confidence.
Adverse events associated with taking opioid pain medications increase in patients who concurrently use sedatives and alcohol. A study in The Journal of Pain, published by the American Pain Society, advises physicians to use caution in prescribing sedatives for patients taking opioids, even if there is no history of substance abuse.
More should be done across Europe to ensure that people with rare forms of cancer are not denied access to the best possible treatment, say the organizers of a major European cancer conference to be held in Milan on 9 and 10 March 2010.
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
› Verified 7 days ago
Dr. William Lyman Rutledge, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9712 W Markham St, Little Rock, AR 72205 Phone: 501-954-8800 Fax: 501-954-8803 | |
Allan Dee Mckenzie, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4523 Woodlawn Dr, Little Rock, AR 72205 Phone: 501-663-2363 Fax: 501-663-2362 | |
Dr. Steven Kyser, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-5050 | |
Kasey Renea Kane, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 S Bowman Rd, Little Rock, AR 72211 Phone: 501-558-4100 | |
Dr. William Wells Burnham, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-1000 Fax: 501-257-5071 | |
Deipti H Trehun, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 530, Little Rock, AR 72205 Phone: 501-686-8000 Fax: 501-686-8421 | |
Dr. Pham Hieu Liem, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St, 748, Little Rock, AR 72205 Phone: 501-686-5944 Fax: 501-686-5884 |